Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-28
2011-06-28
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252160, C514S263200, C514S263220, C514S263370, C514S218000, C514S217060, C544S118000, C544S276000, C540S575000, C540S600000
Reexamination Certificate
active
07968544
ABSTRACT:
The present application includes a compound of Formula I or II:or a pharmaceutically acceptable-salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional active agent.
REFERENCES:
patent: 6329381 (2001-12-01), Kurimoto et al.
patent: 6376501 (2002-04-01), Isobe et al.
patent: 7642350 (2010-01-01), Pryde
patent: 2005/0043239 (2005-02-01), Douangpanya et al.
patent: 2006/0052403 (2006-03-01), Isobe et al.
patent: 2007/0190071 (2007-08-01), Kurimoto et al.
patent: 2008/0008682 (2008-01-01), Chong et al.
patent: 2008/0269240 (2008-10-01), Hashimoto et al.
patent: 2008/0300244 (2008-12-01), Bonnert et al.
patent: 2009/0047249 (2009-02-01), Graupe et al.
patent: 2009/0082332 (2009-03-01), Abbot et al.
patent: 2009/0099216 (2009-04-01), Millichip et al.
patent: 2009/0105212 (2009-04-01), Isobe et al.
patent: 2009/0118263 (2009-05-01), Hashimoto et al.
patent: 2009/0131458 (2009-05-01), Lazarides et al.
patent: 2009/0143400 (2009-06-01), McInally et al.
patent: 2009/0192153 (2009-07-01), Hashimoto et al.
patent: 2009/0202484 (2009-08-01), Chong et al.
patent: 2009/0209524 (2009-08-01), Bennett et al.
patent: 2009/0324551 (2009-12-01), Carson et al.
patent: 2009/0325877 (2009-12-01), Grunt et al.
patent: 2010/0075995 (2010-03-01), Biggadike et al.
patent: 2010/0087443 (2010-04-01), Bonnert et al.
patent: 2010/0093998 (2010-04-01), Isobe et al.
patent: 2010/0099870 (2010-04-01), Isobe et al.
patent: 2010/0120799 (2010-05-01), Lazarides et al.
patent: 2010/0130491 (2010-05-01), Bonnert et al.
patent: 2010/0240623 (2010-09-01), Cook et al.
patent: 2010/0280001 (2010-11-01), Bonnert et al.
patent: 2010/0298364 (2010-11-01), Bennett et al.
patent: 2005/089334 (2005-04-01), None
patent: WO-99/28321 (1999-06-01), None
patent: WO-99/32477 (1999-07-01), None
patent: WO-2004/029054 (2004-04-01), None
patent: WO-2005/016348 (2005-02-01), None
patent: WO-2005/016349 (2005-02-01), None
patent: WO-2005/067901 (2005-07-01), None
patent: WO-2005/112935 (2005-12-01), None
patent: WO-2005/117889 (2005-12-01), None
patent: WO-2005/120511 (2005-12-01), None
patent: WO-2006/089106 (2006-08-01), None
patent: WO-2006/117670 (2006-11-01), None
patent: WO-2007/024707 (2007-03-01), None
patent: WO-2007/034817 (2007-03-01), None
patent: WO-2007/034882 (2007-03-01), None
patent: WO-2007/034917 (2007-03-01), None
patent: WO 2007034817 (2007-03-01), None
patent: WO 2007034917 (2007-03-01), None
patent: WO-2007/089334 (2007-08-01), None
patent: WO-2007/142755 (2007-12-01), None
patent: WO 2008004948 (2008-01-01), None
patent: WO 2010018130 (2010-02-01), None
patent: WO 2010018131 (2010-02-01), None
patent: WO 2010018132 (2010-02-01), None
patent: WO 2010018134 (2010-02-01), None
Kelley, Journal of Medicinal Chemistry (1989), 32(8), 1757-63.
International Search Report for PCT/US2008/007955, Oct. 22, 2008.
Juricova et al. (1995) “Synthesis of Base-Modified ‘Abbreviated’ NAD Analogues,”Collection of Czechoslovak Chemical Communications.. 60 (2), 237-250.
Graupe Michael
Halcomb Randall L.
Berch Mark L
Gilead Sciences, Inc.
McGurl Barry F.
LandOfFree
Modulators of toll-like receptor 7 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of toll-like receptor 7, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of toll-like receptor 7 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2736836